What 400,000 Reddit Posts Reveal About GLP-1 Side Effects

If you've ever searched Reddit for answers about a weird symptom on Ozempic or Mounjaro, you're not alone — and according to new research published in Nature Health, what patients are quietly discussing online may actually be telling us something important that clinical trials missed.

The Study in 60 Seconds

Researchers at the University of Pennsylvania used large language models to comb through 410,198 Reddit posts dated May 2019 through June 2025, identifying 67,008 users who said they were taking semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound). About 43.5% of those users described at least one side effect unprompted, in their own words.

The study, titled "Self-Reported Side Effects of Semaglutide and Tirzepatide in Online Communities", was authored by Neil Sehgal, Jena Shaw Tronieri, Lyle Ungar, and senior author Sharath Chandra Guntuku. It was published in Nature Health in April 2026.

The Familiar Findings

First, the good news: the AI analysis confirmed what clinical trials already tell us. The most commonly reported side effects on Reddit matched the known safety profile almost perfectly:

This alignment actually validates the method. As senior author Sharath Chandra Guntuku explained in the Penn Engineering announcement, catching the well-known side effects proves the AI is picking up real signals — not noise. That matters because it means the unfamiliar findings deserve attention too.

The Surprising Signals

Three categories of symptoms showed up in Reddit conversations that don't appear prominently in current drug labeling or routine adverse-event reports:

A Necessary Reality Check

Before anyone panics, it's worth hearing from the other side. Dr. Yuval Pinto, an obesity and family medicine physician at Johns Hopkins Medicine (who was not involved in the study), raised important caveats in interviews with Everyday Health.

Reddit is anonymous, Pinto pointed out. Researchers can't verify who is posting, whether they're actually taking the medication they claim, what dose they're on, or what else is going on in their health history. There's also no placebo comparison group — so while a given percentage of GLP-1 users report fatigue, we don't know how many non-users on Reddit would report fatigue if asked the same question.

Pinto also raised an important distinction: not every symptom someone experiences while on a medication is caused by that medication. Rapid weight loss itself — regardless of how it's achieved — can cause temporary hair thinning, changes in menstrual cycles, and shifts in energy levels. Some of what patients attribute to the drug may actually be their body adjusting to a significantly different weight.

The study's authors agree. They explicitly state their findings are not causal. The point isn't to prove GLP-1s cause menstrual changes — it's to flag that patients are talking about these experiences consistently enough that clinicians and researchers should pay attention.

Why This Matters for You

If you're on a GLP-1 or considering one, the takeaway isn't fear — it's agency. A few practical lessons emerge from this research:

Your symptoms are data.

Clinical trials capture what researchers ask about. They miss what patients don't think to mention or what doesn't reach a reporting threshold. If something feels off, it's worth noting — even if it's not on the "official" side effect list yet.

Track what you notice.

Keep a simple log: energy levels, cycle changes, temperature sensitivity, sleep quality, mood. A few lines in a notes app once a week gives you and your provider something concrete to work from. Patterns matter more than single data points.

Report symptoms to your prescriber — not just Reddit.

Online communities are valuable for normalizing experiences, but they can't replace a clinician who knows your full history. If you notice something persistent or concerning, tell the doctor who prescribed your medication. That's how side effect reporting actually reaches regulators.

Work with a provider who actually listens.

This study's real subtext is that patients often feel their experiences aren't being heard. A quality telehealth provider should welcome your observations, adjust dosing when needed, and take symptoms seriously — not brush them off as "not a known side effect." If your current provider isn't doing that, you have options.

The Bigger Picture: Social Listening Is Here to Stay

Beyond the GLP-1 findings, this study is a preview of something bigger: AI-assisted "computational social listening" as a legitimate supplement to traditional pharmacovigilance. Clinical trials are rigorous but slow. Adverse event reports to the FDA are thorough but often delayed. Meanwhile, patients are swapping real-time notes online by the millions.

When a medication goes from niche to mainstream almost overnight — as GLP-1s have — that gap between what patients experience and what regulators know matters. Expect to see more studies like this one, applied to everything from compounded peptides to new obesity drugs in the pipeline.

The Bottom Line

410,000 Reddit posts pointed to three potential GLP-1 side effects — menstrual changes, fatigue, and temperature sensitivities — that current drug labeling may be underreporting. The findings aren't proof of causation, and experts are right to be cautious. But the signal is strong enough that patients shouldn't feel dismissed when they bring these experiences up.

If you're on a GLP-1 and something feels off, you're not imagining it. Track it. Report it. And if your current provider isn't engaging with your concerns, find one who will.